RS51109B - Derivati 2-fenilpropionske kiseline i farmaceutske smeše koje ih sadrže - Google Patents
Derivati 2-fenilpropionske kiseline i farmaceutske smeše koje ih sadržeInfo
- Publication number
- RS51109B RS51109B RSP-2009/0568A RSP20090568A RS51109B RS 51109 B RS51109 B RS 51109B RS P20090568 A RSP20090568 A RS P20090568A RS 51109 B RS51109 B RS 51109B
- Authority
- RS
- Serbia
- Prior art keywords
- treatment
- acid derivatives
- prevention
- compounds
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Izvedena jedinjenja 2-(R)-fenilpropionske kiseline sa formulom (I):i njihove farmaceutski prihvatljive soli, gdeR' grupa je odabrana od-H, OH i kada R' je H, R je odabran od:- H, C1-C5-alkila, C3-C6-cikloalkila, C2-C5-alkenila, C1-C5-alkoksi;- heteroarilna grupa, odabrana od supstituisanog i nesupstituisanog piridina, pirimidina, pirola, tiofena, indola, tiazola, oksazola;- aminokiselinski ostatak, koji se sastoji od pravog ili razgranatog C1-C6-alkila, C3-C6-cikloalkila, C2-C6-alkenila, CrC6-fenilalkila, supstituisanog sa još jednom karboksi (COOH) grupom;- ostatak formule -CH2-CH2-Z-(CH2-CH2O)nR' gde je R' H ili C1-C5-alkil, n je ceo broj od 0 do 2 i Z je kiseonik ili sumpor;- ostatak formule -CH2)n-NRaRb, gde je n ceo broj od 0 do 5 i svaki, Ra i Rb, koji mogu biti isti ili različiti, je C1-C6-alkil, C2-C6-alkenil ili, alternativno, Ra i Rb, zajedno sa atomom azota za koji su vezani, obrazuju heterociklus od 3 do 7 članova formule (II):gde W predstavlja jednostruku vezu, O, S, N-Rc, Rc je H, C1-C6-alkil, i n je ceo broj od 0 do 3,- ostatak formule SO2Rd gde je Rd C1-C6-alkil, C3-C6-cikloalkil, C2-C6-alkenil, aril i heteroaril;kada R' je OH, R je odabran od:H, C1-C5-alkila, C3-C6-cikloalkila, C2-C5-alkenila.Prijava sadrži još 7 patentnih zahteva.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04101202 | 2004-03-23 | ||
| PCT/EP2005/051302 WO2005090295A2 (en) | 2004-03-23 | 2005-03-21 | 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS51109B true RS51109B (sr) | 2010-10-31 |
Family
ID=34970877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RSP-2009/0568A RS51109B (sr) | 2004-03-23 | 2005-03-21 | Derivati 2-fenilpropionske kiseline i farmaceutske smeše koje ih sadrže |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US8039656B2 (sr) |
| EP (1) | EP1776336B1 (sr) |
| JP (1) | JP4871257B2 (sr) |
| CN (2) | CN101912382B (sr) |
| AT (1) | ATE444286T1 (sr) |
| AU (1) | AU2005223402B2 (sr) |
| CA (1) | CA2553705C (sr) |
| CY (1) | CY1109687T1 (sr) |
| DE (1) | DE602005016937D1 (sr) |
| DK (1) | DK1776336T3 (sr) |
| ES (1) | ES2333445T3 (sr) |
| HK (2) | HK1101392A1 (sr) |
| HR (1) | HRP20090681T1 (sr) |
| ME (1) | ME01763B (sr) |
| NO (1) | NO337685B1 (sr) |
| PL (1) | PL1776336T3 (sr) |
| PT (1) | PT1776336E (sr) |
| RS (1) | RS51109B (sr) |
| RU (1) | RU2375347C2 (sr) |
| SI (1) | SI1776336T1 (sr) |
| WO (1) | WO2005090295A2 (sr) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2458051C2 (ru) * | 2005-11-24 | 2012-08-10 | ДОМПЕ ФА.Р.МА С.п.А. | (r)-арилалкиламинопроизводные и содержащие их фармацевтические композиции |
| DK2024329T3 (da) * | 2006-05-18 | 2013-11-04 | Dompe Spa | (2r)-2-[(4-sulfonyl)aminophenyl]propanamider og farmaceutiske sammensætninger indeholdende dem |
| ES2394641T3 (es) * | 2006-12-19 | 2013-02-04 | Dompe' S.P.A. | Ácidos 2-aril-2-fluoropropanoicos y derivados y composiciones farmacéuticas que los contienen |
| EP2166006A1 (en) * | 2008-09-18 | 2010-03-24 | Dompe' S.P.A. | 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them |
| EP2308485A1 (en) | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Sulfonamides for the prevention of diabetes |
| EP2308484A1 (en) * | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets |
| EP2316820A1 (en) | 2009-10-28 | 2011-05-04 | Dompe S.p.A. | 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them |
| MD480Z5 (ro) * | 2011-07-07 | 2012-09-30 | Эльвира АНДОН | Metodă de tratament al colitei ulceroase nespecifice acute |
| CN103159650B (zh) * | 2011-12-19 | 2016-04-20 | 天津市国际生物医药联合研究院 | 芳香杂环磺酰胺类化合物的制备及其应用 |
| CN103159649B (zh) * | 2011-12-19 | 2016-03-09 | 天津市国际生物医药联合研究院 | 磺酰胺类化合物的制备及其应用 |
| US10561676B2 (en) * | 2013-08-02 | 2020-02-18 | Syntrix Biosystems Inc. | Method for treating cancer using dual antagonists of CXCR1 and CXCR2 |
| US10046002B2 (en) | 2013-08-02 | 2018-08-14 | Syntrix Biosystems Inc. | Method for treating cancer using chemokine antagonists |
| EP3117835A1 (en) * | 2015-07-14 | 2017-01-18 | Dompé farmaceutici s.p.a. | Il-8 inhibitors for use in the treatment of certain urological disorders |
| EP3192504A1 (en) | 2016-01-15 | 2017-07-19 | Dompé farmaceutici S.p.A. | Il-8 inhibitors for use in the treatment of chemotherapy-induced peripheral neuropathy |
| AU2017207850B2 (en) * | 2016-01-15 | 2022-06-30 | Dompe' Farmaceutici S.P.A. | IL-8 inhibitors for use in the treatment of chemotherapy-induced peripheral neuropathy |
| CN117503933A (zh) * | 2016-10-03 | 2024-02-06 | 儿童医疗中心公司 | 糖尿病肾病的预防和治疗 |
| EP3342407A1 (en) | 2017-01-03 | 2018-07-04 | Dompé farmaceutici S.p.A. | Il-8 inihibitors for use in the treatment of some urological disorders |
| EP3409277A1 (en) * | 2017-05-30 | 2018-12-05 | Dompé farmaceutici s.p.a. | Il-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infections |
| EP3476390A1 (en) | 2017-10-24 | 2019-05-01 | Dompé farmaceutici S.p.A. | Il-8 inhibitors for use in the treatment of sarcomas |
| EP3498269A1 (en) * | 2017-12-12 | 2019-06-19 | Dompé farmaceutici S.p.A. | C5ar inhibitors for use in the treatment of chemotherapy-induced iatrogenic pain |
| EP3868368A1 (en) | 2020-02-21 | 2021-08-25 | Dompe' Farmaceutici S.P.A. | Cxcl8 (interleukin-8) activity inhibitor and corticosteroid combination and pharmaceutical composition and use thereof |
| EP3868369A1 (en) | 2020-02-21 | 2021-08-25 | Dompe' Farmaceutici S.P.A. | Cxcl8 inhibitor and pharmaceutical composition thereof for use in the treatment of cancer-related fatigue |
| WO2021191305A1 (en) | 2020-03-26 | 2021-09-30 | Dompe' Farmaceutici Spa | Cxcl8 inhibitors for use in the treatment of covid-19 |
| EP3884932A1 (en) | 2020-03-26 | 2021-09-29 | Dompe' Farmaceutici S.P.A. | Cxcl8 inhibitors for use in the treatment of covid-19 |
| EP4008325A1 (en) | 2020-12-02 | 2022-06-08 | Dompe' Farmaceutici S.P.A. | Cxcl8 inhibitors for use in the treatment of covid-19 |
| CA3196979A1 (en) * | 2020-11-05 | 2022-05-12 | Icahn School Of Medicine At Mount Sinai | Cxcr1/cxcr2 inhibitors for use in treating myelofibrosis |
| EP4052702A1 (en) | 2021-03-04 | 2022-09-07 | Dompé farmaceutici S.p.a. | Cxcl8 inhibitor and pharmaceutical composition thereof for use in the treatment of seizures |
| EP4397305A1 (en) | 2023-01-05 | 2024-07-10 | Dompe' Farmaceutici S.P.A. | Cxcl8 inhibitors for use in the treatment of ocular mucous membrane pemphigoid and/or oral mucous membrane pemphigoid |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE242208T1 (de) * | 1997-01-29 | 2003-06-15 | Pfizer | Sulfonylharnstoff-derivate und ihre verwendung in der kontrolle der interleukin-1-aktivität |
| IT1303249B1 (it) * | 1998-10-23 | 2000-11-06 | Dompe Spa | Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono. |
| IT1317826B1 (it) * | 2000-02-11 | 2003-07-15 | Dompe Spa | Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8. |
| ITMI20010395A1 (it) * | 2001-02-27 | 2002-08-27 | Dompe Spa | Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate |
| ITMI20012025A1 (it) * | 2001-09-28 | 2003-03-28 | Dompe Spa | Sali di ammonio quaternari di omega-amminoalchilammidi di acidi r 2-aril-propionici e composizioni farmaceutiche che li contengono |
| ITMI20012434A1 (it) | 2001-11-20 | 2003-05-20 | Dompe Spa | Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono |
| WO2004069782A2 (en) * | 2003-02-06 | 2004-08-19 | Dompe' S.P.A. | 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
| JP4795242B2 (ja) * | 2003-09-25 | 2011-10-19 | ドムペ・ファ．ル．マ・ソチエタ・ペル・アツィオーニ | アミジン及びその誘導体並びにそれを含有する医薬組成物 |
-
2005
- 2005-03-21 CN CN2010102609529A patent/CN101912382B/zh active Active
- 2005-03-21 PL PL05729779T patent/PL1776336T3/pl unknown
- 2005-03-21 AT AT05729779T patent/ATE444286T1/de active
- 2005-03-21 ME MEP-2009-568A patent/ME01763B/me unknown
- 2005-03-21 RU RU2006137272/04A patent/RU2375347C2/ru active
- 2005-03-21 SI SI200530869T patent/SI1776336T1/sl unknown
- 2005-03-21 PT PT05729779T patent/PT1776336E/pt unknown
- 2005-03-21 CA CA2553705A patent/CA2553705C/en active Active
- 2005-03-21 ES ES05729779T patent/ES2333445T3/es active Active
- 2005-03-21 DK DK05729779.8T patent/DK1776336T3/da active
- 2005-03-21 JP JP2007504413A patent/JP4871257B2/ja active Active
- 2005-03-21 WO PCT/EP2005/051302 patent/WO2005090295A2/en active Application Filing
- 2005-03-21 AU AU2005223402A patent/AU2005223402B2/en active Active
- 2005-03-21 EP EP05729779A patent/EP1776336B1/en active Active
- 2005-03-21 CN CN200580008890XA patent/CN1934077B/zh active Active
- 2005-03-21 DE DE602005016937T patent/DE602005016937D1/de active Active
- 2005-03-21 RS RSP-2009/0568A patent/RS51109B/sr unknown
- 2005-03-21 US US10/592,572 patent/US8039656B2/en active Active
-
2006
- 2006-10-20 NO NO20064766A patent/NO337685B1/no unknown
-
2007
- 2007-08-31 HK HK07109494.5A patent/HK1101392A1/xx unknown
-
2009
- 2009-12-18 CY CY20091101318T patent/CY1109687T1/el unknown
- 2009-12-22 HR HR20090681T patent/HRP20090681T1/hr unknown
-
2011
- 2011-03-10 HK HK11102410.5A patent/HK1148219A1/xx unknown
- 2011-09-15 US US13/234,125 patent/US8293788B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1148219A1 (en) | 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them 2- | |
| HK1089431A1 (en) | Sulfonic acids, their derivatives and pharmaceutical compositions containing them | |
| Waelchli et al. | Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK | |
| NO20054017L (no) | 2-aryl-eddiksyrer, deres derivater og farmasoytisk sammensetninger som inneholder dem | |
| NO20074641L (no) | 1-Acetic Acid-Indole Derivatives with PGD2 Antagonist Activity | |
| Schrøder et al. | The identification of AF38469: an orally bioavailable inhibitor of the VPS10P family sorting receptor Sortilin | |
| MXPA04004744A (es) | Acidos 2-aril-propionicos y composiciones farmaceuticas que contienen a los mismo. | |
| Asaki et al. | Design and synthesis of 3-substituted benzamide derivatives as Bcr-Abl kinase inhibitors | |
| HRP20090489T1 (hr) | Hidantoinski derivati korisni kao inhibitori metaloproteinaza | |
| Walker et al. | Identification of SD-0006, a potent diaryl pyrazole inhibitor of p38 MAP kinase | |
| George et al. | Discovery of thieno [2, 3-c] pyridines as potent COT inhibitors | |
| NO20080165L (no) | Alfa-(aryl-OR heteroaryl-metyl)-beta piperidinopropanamidforbindelser som ORL1-receptorantagonister | |
| DE602006007210D1 (de) | Metaboliten aus 2-arylpropionsäure-derivaten und pharmazeutische zusammensetzungen damit | |
| YU62801A (sh) | Derivati 4-heterociklilsulfonamidil-6-metoksi-5-(2-metoksi- fenoksi)-2-piridil- piridimina, njihovo dobivanje i primena kao antagonisti endotelinskih receptora | |
| Yokokawa et al. | Recent advances in the discovery of non-peptidic direct renin inhibitors as antihypertensives: new patent applications in years 2000–2008 | |
| Laliberté et al. | Discovery of a series of aryl-N-(3-(alkylamino)-5-(trifluoromethyl) phenyl) benzamides as TRPA1 antagonists | |
| Wei et al. | CCR5 receptor antagonists: Discovery and SAR study of guanylhydrazone derivatives | |
| Shishido et al. | Synthesis of benzamide derivatives as TRPV1 antagonists | |
| Venkatraman et al. | Influence of acid surrogates toward potency of VLA-4 antagonist |